Mathias Hothum

Dr. Mathias Hothum is a Chairman-Supervisory Board at GEUDER AG, a Co-Managing Director at TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG, a Managing Director at dievini Hopp BioTech holding GmbH & Co. KG, a Managing Director at dievini Verwaltungs GmbH, a Managing Director at Hmm Consulting and a Managing Director at OH Venture Management GmbH.
He is on the Board of Directors at Immatics NV, CureVac NV, Heidelberg Pharma AG, Apogenix AG, CureVac SE, Molecular Health GmbH and Novaliq GmbH.
Dr. Hothum was previously employed as a Co-Managing Director by Drug Delivery Systems Beteiligungs GmbH, a Non-Executive Director by AC Immune SA, a Chairman by Joimax GmbH, and a Member-Supervisory Board by Molecular Health, Inc. He also served on the board at Weinheim 216 GmbH & Co. KG.
He received his undergraduate degree from the University of Mannheim and a doctorate degree from Otto-von-Guericke-Universität Magdeburg.